Grant
Translational Studies for the Phase 1/2 Trial of VS-6766 + Defactinib and GEM + Nab-P in Metastatic PDAC
- Fiscal years counted
- 2022
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try